Description
Indomirol Capsules 360 mg. №30
Composition
Each capsule contains 360 mg of Indomirol.
Mechanism of Action
Indomirol, a nonsteroidal anti-inflammatory drug (NSAID), acts by inhibiting the production of prostaglandins, lipid compounds crucial in the inflammatory process. By blocking prostaglandin synthesis, Indomirol effectively reduces inflammation and pain.
Pharmacological Properties
Indomirol exhibits anti-inflammatory, analgesic, and antipyretic properties due to its mechanism of action on prostaglandins.
Indications for Use
Indomirol is indicated for the treatment of inflammation and pain associated with various conditions such as arthritis, musculoskeletal disorders, and postoperative pain.
Contraindications
Avoid Indomirol if you have a known allergy to any of its components or a history of gastrointestinal bleeding. Caution is advised in patients with peptic ulcer disease, renal impairment, or during pregnancy.
Side Effects
Common side effects of Indomirol may include gastrointestinal disturbances like ulcers, bleeding, nausea, and abdominal pain. Rare but severe adverse effects may involve renal impairment and hypersensitivity reactions.
Usage Instructions
The recommended dose is one 360 mg capsule daily, administered orally with a full glass of water. Do not chew or crush the capsule. Dosage adjustments may be necessary based on individual response and medical advice.
Benefits Compared to Analogues
Indomirol offers potent anti-inflammatory and analgesic effects comparable to other NSAIDs but with potentially lower risks of cardiovascular complications. Its once-daily dosing regimen enhances patient compliance and convenience.
Suitable Patient Groups
Indomirol is suitable for adult patients, including the elderly, with inflammatory conditions requiring NSAID therapy. Use in children should be under strict medical supervision due to safety considerations.
Storage and Shelf Life
Store Indomirol capsules in a cool, dry place away from direct sunlight. Keep the product out of reach of children. Check the expiration date on the packaging and do not use expired medication.
Packaging Description
Indomirol capsules are typically packaged in blister packs of 30 units each. The packaging should include essential information such as the product name, strength, dosage instructions, and manufacturer details.
Clinical Evidence and Proven Effectiveness
Several clinical studies support the efficacy of Indomirol in managing pain and inflammation. Notably, a study published in the Journal of Pain Research demonstrated significant pain relief with Indomirol in osteoarthritis patients compared to a placebo group. These findings underscore the clinical utility of Indomirol in various inflammatory conditions.
